全文获取类型
收费全文 | 1854480篇 |
免费 | 127230篇 |
国内免费 | 3509篇 |
专业分类
耳鼻咽喉 | 26274篇 |
儿科学 | 60059篇 |
妇产科学 | 51848篇 |
基础医学 | 262913篇 |
口腔科学 | 51536篇 |
临床医学 | 159868篇 |
内科学 | 361279篇 |
皮肤病学 | 41091篇 |
神经病学 | 143750篇 |
特种医学 | 74226篇 |
外国民族医学 | 535篇 |
外科学 | 286052篇 |
综合类 | 38486篇 |
现状与发展 | 1篇 |
一般理论 | 495篇 |
预防医学 | 132062篇 |
眼科学 | 42394篇 |
药学 | 141213篇 |
7篇 | |
中国医学 | 4352篇 |
肿瘤学 | 106778篇 |
出版年
2018年 | 18988篇 |
2017年 | 14982篇 |
2016年 | 16573篇 |
2015年 | 18582篇 |
2014年 | 25905篇 |
2013年 | 38982篇 |
2012年 | 52663篇 |
2011年 | 55890篇 |
2010年 | 33472篇 |
2009年 | 31548篇 |
2008年 | 52787篇 |
2007年 | 56225篇 |
2006年 | 56976篇 |
2005年 | 54993篇 |
2004年 | 52694篇 |
2003年 | 50871篇 |
2002年 | 49563篇 |
2001年 | 93766篇 |
2000年 | 96338篇 |
1999年 | 81139篇 |
1998年 | 21128篇 |
1997年 | 18924篇 |
1996年 | 18930篇 |
1995年 | 17614篇 |
1994年 | 16415篇 |
1993年 | 15489篇 |
1992年 | 61654篇 |
1991年 | 59164篇 |
1990年 | 58069篇 |
1989年 | 55889篇 |
1988年 | 51097篇 |
1987年 | 49921篇 |
1986年 | 47373篇 |
1985年 | 44901篇 |
1984年 | 32908篇 |
1983年 | 27810篇 |
1982年 | 15949篇 |
1981年 | 13921篇 |
1979年 | 29907篇 |
1978年 | 20379篇 |
1977年 | 17899篇 |
1976年 | 16089篇 |
1975年 | 18054篇 |
1974年 | 21286篇 |
1973年 | 20456篇 |
1972年 | 19508篇 |
1971年 | 18153篇 |
1970年 | 17066篇 |
1969年 | 16307篇 |
1968年 | 14969篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
991.
Differential diagnosis of poisoning by North American mushrooms, with particular emphasis on Amanita phalloides-like intoxication 总被引:2,自引:0,他引:2
It is possible to determine the management and prognosis of mushroom poisoning from the history and initial symptoms with a high degree of confidence. The most important intoxications are those involving Amanita phalloides or other potentially fatal amatoxin-containing mushrooms, which have a latent period of ten to 12 hours before the patient becomes symptomatic. Because aggressive gastroenteric decontamination can reduce the extent of hepatic damage, it is important to attempt to determine during this asymptomatic period whether amatoxin exposure has occurred. Various laboratory methods that might be useful are reviewed. 相似文献
992.
A thyroid medullary carcinoma from a man with the multiple endocrine neoplasia syndrome Type IIB was examined for the presence of opioid peptides. The tumor contained peptides derived from all three opioid precursors: pro-opiomelanocortin (POMC), pro-dynorphin, and pro-enkephalin. The tissue concentrations of the various opioid peptides varied considerably. beta-Endorphin, a POMC-derived peptide, was present in concentrations between 9 to 12 pmoles/g tissue; 8 pmoles/g tissue of alpha-neo-endorphin, a pro-dynorphin-derived product, were seen, whereas the pro-enkephalin-associated peptides were present in much lower concentrations (0.6-2.1 pmoles/g tissue). Immunohistochemical studies showed scattered opioid-positive cells in the tumor tissue and in two other thyroid medullary carcinomas. These data demonstrate that malignant neuroendocrine tumors may contain peptides derived from all three families of the endogenous opioids. 相似文献
993.
994.
995.
In rats treat-given hydrocortisone to suppress healing, tensile strength of the skin at the site of an incision wound was significantly higher in rats locally treated with carnosine than in untreated animals. Similar effects on the tensile strength of the skin were observed by the administration of beta-alanine and histidine, but not of beta-alanine alone. Exogenous carnosine was degraded in the body by carnosinase and histidine decarboxylase to yield histamine. Since beta-alanine, the other degradation product of carnosine, was found to stimulate the biosynthesis of nucleic acids and collagen, histamine derived from carnosine is considered to have enhanced the process of wound healing by stimulating effusion at the initial stage of inflammation. Thus, the enhancement by carnosine of wound healing may be ascribed to stimulation of early effusion by histamine and of collagen biosynthesis by beta-alanine. The wound-healing effects of carnosine were further demonstrated by the observation that carnosine significantly increased granulation suppressed by cortisone, mitomycin C, 5-fluorouracil, and bleomycin. 相似文献
996.
997.
Clinical experience of phototherapy for non-haemolytic hyperbilirubinaemia in 3999 infants in Kandang Kerbau Hospital, Singapore, is documented. Phototherapy was most effective in extremely preterm infants with very low birth weight (gestation less than or equal to 32 weeks, birth weight less than or equal to 1500 g) and least effective in full term infants with very low birth weight (gestation greater than or equal to 37 weeks, birth weight less than or equal to 1500 g) and large preterm infants (gestation less than 37 weeks, birth weight greater than 2270 g). Overall, phototherapy was effective in almost all the infants, with a failure rate of only 2.00/1000 infants. No characteristic features common to all the failures could be detected. The bilirubin rebound was usually mild; repeat phototherapy was required in only 30 infants (7.50/1000), with the response to the second exposure comparable to that to the first. No infant required a third exposure. All the infants tolerated phototherapy well, none developing any illness that could be attributed to the treatment. This clinical experience shows that phototherapy for the treatment of nonhaemolytic hyperbilirubinaemia is effective and safe. 相似文献
998.
V K Ryzhkov N A Borisova E M Gapchenko I A Dmitrieva 《Vestnik khirurgii imeni I. I. Grekova》1986,136(1):11-14
Roentgen endovascular occlusion with spiral emboli was used in 240 patients with different diseases. The introduction of spiral emboli into the arteries of abdominal and retroperitoneal organs was fulfilled through usual angiographic catheters. Duration of the arterial occlusion was checked up in the following angiographic examinations and showed the devices described to be appropriate for a continuous arterial blockade. No complications resulting from the introduction of the spiral embolus were noted. 相似文献
999.
K Suzuki K Takanashi Y Naide T Fujita T Ogawa S Hirabayashi H Tamai M Yanaoka K Ishiguro H Asano 《Hinyokika kiyo. Acta urologica Japonica》1986,32(9):1387-1408
MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for over 10 days. The efficacy rate of 26 patients who were evaluable in the early phase (4-7 days) was 88.5%, while it became up to 92.3% in the final phase judgment. As for clinical usefulness, the result was obtained to be as high as that of the clinical efficacy. In bacteriological study, 35 strains were clinically isolated including 7 strains of P. aeruginosa from UTI. All the strains disappeared with an eradication rate of 100% after treatment. Strains appearing after Imipenem/Cilastatin sodium treatment mainly consisted of fungi. Usefulness judgements tended to be greater in the final phase than in the early phase. As for side effects, vomiting was recorded in one case, in which the administration was discontinued. In laboratory findings there were 3 cases with elevated GPT, 2 cases with elevated GOT, one case with elevated gamma-GTP, one with thrombocytopenia, and one with eosinophilia each, but these abnormal values were slight and transient. In summary our clinical study showed that Imipenem/Cilastatin sodium was a very effective antibiotic in treatment on moderate or serious UTI or preventive use for infections in compromised hosts. Considering the features of this agent, it might be more effective and useful for clinical use in treatment on polymicrobial infections including stubborn organisms than any other antimicrobial compounds. Furthermore, it was safe and well tolerable in a long term treatment. 相似文献
1000.
RenNew-D (Alcide), a novel demand-release sporocidal agent, was employed instead of formaldehyde in the reprocessing for reuse of cuprophan hollow fiber dialyzers (Gambro) and the performance of these dialyzers was evaluated over 40 consecutive dialyses in six patients on maintenance hemodialysis. When RenNew-D was part of automated reprocessing performed with 4.3% bleach as specified by the manufacturer (Lixivitron), dialyzer survival was prolonged (16.7 +/- 7.2 uses) and hemodialysis neutropenia was unchanged with reuse. When RenNew-D was part of manual reprocessing conducted in the absence of bleach, marked improvement in dialyzer biocompatibility was observed but with a decreased survival (4.8 +/- 3.0). The majority of dialyzer failures were due to a fall in fiber bundle volume below a 85% set limit. Small solute clearances were maintained with both types of reprocessing. Dialyses were well tolerated throughout. Our data suggest that RenNew-D is a safe and efficacious product which can serve as a valuable alternative to formaldehyde for the purpose of dialyzer reuse. 相似文献